CC Pharma GmbH Sustainability Profile
CC Pharma GmbH, headquartered in Germany, is a prominent player in the pharmaceutical distribution industry. Founded in 1998, the company has established itself as a trusted partner in the supply of high-quality pharmaceutical products across Europe, with a strong operational presence in various key markets. Specialising in the import and distribution of prescription medications, CC Pharma is known for its extensive portfolio that includes both generic and branded drugs. The company’s commitment to quality and compliance with stringent regulatory standards sets it apart in a competitive landscape. With a focus on customer satisfaction and efficient logistics, CC Pharma GmbH has achieved significant milestones, positioning itself as a reliable source for healthcare providers. Its dedication to innovation and excellence has earned the company a notable reputation within the pharmaceutical sector.
DitchCarbon Score
How does CC Pharma GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CC Pharma GmbH's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CC Pharma GmbH's reported carbon emissions
CC Pharma GmbH, headquartered in Germany, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Tilray Brands, Inc., which may influence its climate commitments and emissions reporting. However, no specific reduction targets or initiatives have been documented for CC Pharma GmbH. As part of its corporate family, CC Pharma may align with broader sustainability efforts initiated by Tilray Brands, Inc., although specific emissions data and reduction targets have not been disclosed. The absence of detailed emissions figures suggests that CC Pharma is in the early stages of formalising its climate strategy or reporting. In the context of the pharmaceutical industry, companies are increasingly focusing on reducing their carbon footprints and committing to science-based targets. While CC Pharma GmbH has not yet published its own emissions data or climate commitments, it is essential for the company to develop a robust strategy to address climate change and contribute to global sustainability goals.
How Carbon Intensive is CC Pharma GmbH's Industry?
How Carbon Intensive is CC Pharma GmbH's Location?
CC Pharma GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CC Pharma GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
